Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia

16Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

To review the experience of a child psychiatric clinic regarding co-morbidity and treatment characteristics of children with attention deficit hyperactivity disorder (ADHD), a retrospective study was done on patients under 19 years who were attending the clinic and were diagnosed with ADHD. Co-morbidity and treatment characteristics were also studied. ADHD was diagnosed in 25.5% of the patients. Of these, 28.3% had coexistent expressive language disorder and 38.7% coexistent mild mental retardation. A psychostimulant (methylphenidate) was prescribed to 23.6% while antidepressants (primarily imipramine) were prescribed to 35.9%. Behavioural therapy was the most commonly offered psychotherapy. Antidepressants were used more than psychostimulants. Psychotropics had a more beneficial effect than psychotherapy.

Cite

CITATION STYLE

APA

Al-Haidar, F. A. (2003). Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia. Eastern Mediterranean Health Journal. World Health Organization. https://doi.org/10.26719/2003.9.5-6.988

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free